Genome & Company Market Cap

Genome & Company has a market cap or net worth of 88.35 billion as of January 22, 2025. Its market cap has decreased by -48.33% in one year.

Market Cap

88.35B

Enterprise Value

92.21B

Revenue

24.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,845.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 88.35B, an increase of 22.92%. That is a compound annual growth rate of 3.45%.

Market Cap History

Date	Market Cap	% Change
Jan 21, 2025	88.51B	3.87%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	1,048.46B	224.28%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Electronics	355.59T
SK hynix	150.21T
LG Energy Solution	82.95T
Samsung Biologics Co.,Ltd.	71.25T
Hyundai Motor Company	45.49T
Kia Corporation	39.35T
Celltrion	38.12T
KB Financial Group	33.29T

Market Cap Rankings